Table 3.
Association of severe COVID-19 with LZTFL1 polymorphisms in an allele model.
| rs35044562genotype | |||||||
|---|---|---|---|---|---|---|---|
| COVID-19 Clinical Manifestations | AA | AG + GG | χ2 | d.f. | p | OR (95% CI) | |
| Severe (n = 40) | 22 | 18 | |||||
| vs | |||||||
| Asymptomatic (n = 120) | 104 | 16 | 17.98 | 1 | 0.000 | 5.32 | (2.53 - 12.01) |
| Pauci-symptomatic (n = 90) | 80 | 10 | 18.82 | 1 | 0.000 | 6.55 | (2.65 - 16.19) |
| Moderate (n = 108) | 86 | 22 | 8.978 | 1 | 0.003 | 3.20 | (1.47 - 6.97) |
| Asymptomatic, Pauci-symptomatic, Moderate (n = 318) |
270 | 48 | 21.13 | 1 | 0.000 | 4.60 | (2.29 - 9.22) |
X2 = Chi square; d.f., degrees of freedom; p, p value; OR, Odds ratio (s), CI, confidence intervals.